Sign up
Tech Capital

Amazon now carrying NovaBay Pharmaceuticals’ Avenova eye-care product; shares skyrocket

Avenova is available without a prescription on Amazon's new direct direct-to-consumer online channel
eye
The Avenova spray removes bacteria and debris on and around the eyelid that contribute to bacterial eye infections

Shares of NovaBay Pharmaceuticals Inc (NYSEAMERICAN:NBY) increased more than six-fold Monday after the company announced that its Avenova eye-care product is now available without a prescription at Amazon.com.

The Emeryville, California-based biopharmaceutical company said customers can purchase Avenova on Amazon.com Inc's (NASDAQ:AMZN) new direct direct-to-consumer online channel.

NovaBay’s stock exploded 541% to $2.04 a share on heavy volume Monday afternoon. 

Treating dry eyes

Avenova, a spray, is designed for the removal of bacteria and debris on and around the eyelid margin that contribute to bacterial eye infections, which represent approximately 85% of the dry eye market, the company said.

“While prescription Avenova continues to be available through retail pharmacies and direct in-office sales by certain eye-care specialists, patients and physicians have asked for greater accessibility to the product," said CEO Justin Hall. "In response, we are launching our new US direct-to-consumer channel, which is a significant step in ensuring easy access at an affordable price."

Avenova, or Avenova Direct as the online version is called, is available from Amazon in the US in a 20 milliliter size for $29.99, the company said.

-- updates stock price --- 

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

1556543955_patrick.graham.jpg


Register here to be notified of future Company articles
View full profile View Profile
View All

© tech Capital 2019

Tech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed tech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Tech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Technology market.